EGFR and inflammatory breast carcinoma: We cannot exclude the possibility that other mechanisms contribute to the tumor suppressive function of PLEKHA7 in IBC, including inhibiting p120 signaling, or suppressing E-cadherin/Epidermal growth factor receptor (EGFR) signaling [37].